Federal
Register Notices > Notices
of Registration - 2003 > AccusStandard Inc
[Federal Register: October 7, 2003 (Volume 68,
Number 194)]
[Notices]
[Page 57928-57929]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07oc03-87]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By Notice dated June 6, 2003, and published in the
Federal Register on June 19, 2003, (68 FR 26841), AccusStandard Inc.,
125 Market Street, New Haven, Connecticut 06513, made application by
renewal and on May 7, 2003, by letter to the Drug Enforcement
Administration to be registered as a bulk manufacturer of the basic
classes of Schedule I and II controlled substances listed below:
Drug |
Schedule |
Cathinone (1235) |
I |
Methcathinone (1237) |
I |
N-Ethylamphetamine (1475) |
I |
N,N-Dimethylamphetamine (1480) |
I |
Fenethylline (1503) |
I |
Aminorex (1585) |
I |
4-Methylaminorex (cis isomer)
(1590) |
I |
Gamma hydroxybutyric acid
(2010) |
I |
Methaqualone (2565) |
I |
Mecloqualone (2372) |
I |
Alpha-Ethyltryptamine (7249) |
I |
Ibogaine (7260) |
I |
Lysergic acid diethylamide
(7315) |
I |
Tetrahydrocannabinols (7370) |
I |
Mescaline (7381) |
I |
3,4,5-Trimethoxyamphetamine
(7390) |
I |
4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
4-methyl-2,5-dimethoxyamphetamine
(7395) |
I |
2,5-Dimethoxymphetamine (7396) |
I |
2,5-Dimethoxy-4-ethylamphetamine
(7399) |
I |
3,5-Methylenedioxyamphetamine
(7400) |
I |
5-Methoxy-3,4-methylenedioxyamphetamine
(7401) |
I |
N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
3,4-Methylenediocy-N-ethylamphetamine
(7404) |
I |
3,4-Methylenedioxymethamphetamine
(7405) |
I |
4-Methoxyamphetamine (7411) |
I |
Befotenine (7433) |
I |
Diethyltryptamine (7434) |
I |
Dimethyltryptamine (7435) |
I |
Psilocybin (7437) |
I |
Psilocyn (7438) |
I |
N-Ethyl-1-phenylcyclohexylamine
(7455) |
I |
1-(1-Phenylcyclohexyl)
pyrrolidine (PCPY) (7458) |
I |
Noracymethadol (9633) |
I |
Norlevorphanol (9634) |
I |
Normethadone (9635) |
I |
Norpipanone (9636) |
I |
Phenadoxone (9637) |
I |
Phenampromide (9638) |
I |
Phenoperidine (9641) |
I |
Piritramide (9642) |
I |
Proheptazine (9643) |
I |
Properidine (9644) |
I |
Racemoramide (9645) |
I |
Trimeperidine (9646) |
I |
Phenomorphan (9647) |
I |
Propiram (9649) |
I |
1-Methyl-4-phenyl-4-propionoxypiperidine
(9661) |
I |
1- (2-Phenylethyl)
-4-phenyl-4-acetoxypiperidine (9663) |
I |
Tilidine (9750) |
I |
Para-Fluorofentanyl (9812) |
I |
3-Methylfentanyl (9813) |
I |
Alpha-Methylfentanyl (9814) |
I |
Acetyl-alpha-methylfentanyl
(9815) |
I |
Benzylfentanyl (9818) |
I |
Beta-Hydroxyfentanyl (9830) |
I |
Beta-Hydroxy-3-methylfentanyl
(9831) |
I |
Alpha-Methylthiofentanyl (9832) |
I |
3-Methylthiofentanyl (9833) |
I |
Thenylfentanyl (9834) |
I |
Thiofentanyl (9835) |
I |
Amphetamine (1100) |
II |
Methamphetamine (1105) |
II |
Phenmetrazine (1631) |
II |
Methylphenidate (1724) |
II |
Amobarbital (2125) |
II |
Pentobarbital (2270) |
II |
Secobarbital (2315) |
II |
Glutethimide (2250) |
II |
Nabilone (7379) |
II |
1-Phenylcylohexylamine (7460) |
II |
Phencyclidine (7471) |
II |
Phenylacetone (8501) |
II |
1-Piperidinocyclohexane-carbonitrile
(8603) |
II |
Alphaprodine (9010) |
II |
Anileridine (9020) |
II |
Cocaine (9041) |
II |
Codeine (9050) |
II |
Diprenorphine (9058) |
II |
Etorphine HCL (9059) |
II |
Dihydrocodeine (9120) |
II |
Oxycodone (9143) |
II |
Hydromorphone (9150) |
II |
Diphenoxylate (9170) |
II |
Benzoylecgonine (9180) |
II |
Ecgonine (9180) |
II |
Ethylmorphine (9190) |
II |
Hydrocodone (9193) |
II |
Levomethorphan (9210) |
II |
Levorphanol (9220) |
II |
Isomethadone (9226) |
II |
Meperidine (9230) |
II |
Meperidine intermediate-A
(9232) |
II |
Meperidine intermediate-B
(9233) |
II |
Meperidine intermediate-C
(9234) |
II |
Metazocine (9240) |
II |
Methadone (9250) |
II |
Methadone intermediate (9254) |
II |
Metopon (9260) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Dihydroetorphine (9334) |
II |
Opium, raw (9600) |
II |
Opium tincture (9630) |
II |
Opium powered (9639) |
II |
Levo-alphacetylmethadol (9648) |
II |
Oxymorphone (9652) |
II |
Phenazocine (9715) |
II |
Piminodine (9730) |
II |
Racemethorphan (9732) |
II |
Racemorphan (9733) |
II |
Alfentanil (9737) |
II |
Remifentanil (9739) |
II |
[[Page 57929]] |
II |
Sufentanil (9740) |
II |
Carfentanil (9743) |
II |
Bezitramide (9800) |
II |
Fentanyl (9801) |
II |
Moramide-intermediate (9802) |
II |
The firm plans to manufacture small quantities of
bulk material for use in reference standards.
No comments or objections have been received. DEA
has considered the factors in Title
21, United States Code, Section 823(a) and determined that the
registration of AccuStandard Inc. to manufacture the listed controlled
substances is consistent with the public interest at this time. DEA has
investigated AccuStandard Inc. to ensure that the company's registration
is consistent with the public interest. This investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant to
21 U.S.C. 823 and 28 CFR
0.100 and 0.104, the Deputy Assistant Administrator, Office of
Diversion Control, hereby orders that the application submitted by the
above firm for registration as a bulk manufacturer of the basic classes
of controlled substances listed is granted.
Dated: September 17, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-25308 Filed 10-6-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|